Skip Navigation

This Article
Right arrow Print PDF (1023K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Geballe, A. P.
Right arrow Articles by Gray, M K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geballe, A. P.
Right arrow Articles by Gray, M K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1992, Vol. 20, No. 16 4291-4297
© 1992


MOLECULAR BIOLOGY

Variable inhibition of cell-free translation by HIV–1 transcript leader sequences

Adam P. Geballe and M Kymne Gray

Department of Molecular Medicine, Fred Hutchinson Cancer Reserach Center 1124 Columbia Street, Seattle, WA 98104, USA

Received April 20, 1992. Revised July 18, 1992. Accepted July 18, 1992.

The 5' ends of all human immunodeficiency virus type I (HIV–1) transcripts have the potential to coordinately regulate translation of HIV–1 mRNAs. Conflicting observations of the translational impact of these sequences in various systems stimulated these analyses of translation in reticulocyte lysates. We report a sensitive, rapid, quantitative, and inexpensive cell-free translation assay in which translational efficiency is monitored by enzymatic assay of the translation products. Using this assay and conventional radlolabeling assays, we demonstrate that the HIV–1 transcript leader inhibits downstream translation and that the stem-loop structure is required. Under our assay conditions, this Inhibition occurs predominantly in els and is not mediated by the 68 kD, interferon-Induced, double-stranded RNA-activated kinase (p68). However, under other assay conditions the HIV–1 leader may activate p68 and inhibit translation in trans. We show that variation between individual preparations of cell-free extracts can dramatically alter the magnitude of the translational inhibition by the HIV–1 leader. Further, we provide evidence that a heat-labile factor Is required for efficient translation of transcripts containing the HIV–1 leader. These observations provide a foundation for identifying factors required fortranslation of HIV–1 transcripts.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
C. Bolinger, A. Yilmaz, T. R. Hartman, M. B. Kovacic, S. Fernandez, J. Ye, M. Forget, P. L. Green, and K. Boris-Lawrie
RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1
Nucleic Acids Res., April 10, 2007; (2007) gkm124v1.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Dugre-Brisson, G. Elvira, K. Boulay, L. Chatel-Chaix, A. J. Mouland, and L. DesGroseillers
Interaction of Staufen1 with the 5' end of mRNA facilitates translation of these RNAs
Nucleic Acids Res., August 26, 2005; 33(15): 4797 - 4812.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Roberts and K. Boris-Lawrie
Primary Sequence and Secondary Structure Motifs in Spleen Necrosis Virus RU5 Confer Translational Utilization of Unspliced Human Immunodeficiency Virus Type 1 Reporter RNA
J. Virol., November 15, 2003; 77(22): 11973 - 11984.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Dorin, M. C. Bonnet, S. Bannwarth, A. Gatignol, E. F. Meurs, and C. Vaquero
The TAR RNA-binding Protein, TRBP, Stimulates the Expression of TAR-containing RNAs in Vitro and in Vivo Independently of Its Ability to Inhibit the dsRNA-dependent Kinase PKR
J. Biol. Chem., February 7, 2003; 278(7): 4440 - 4448.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. M. Janzen, L. Frolova, and A. P. Geballe
Inhibition of Translation Termination Mediated by an Interaction of Eukaryotic Release Factor 1 with a Nascent Peptidyl-tRNA
Mol. Cell. Biol., December 15, 2002; 22(24): 8562 - 8570.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Hull and K. Boris-Lawrie
RU5 of Mason-Pfizer Monkey Virus 5' Long Terminal Repeat Enhances Cytoplasmic Expression of Human Immunodeficiency Virus Type 1 gag-pol and Nonviral Reporter RNA
J. Virol., September 11, 2002; 76(20): 10211 - 10218.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Butsch and K. Boris-Lawrie
Destiny of Unspliced Retroviral RNA: Ribosome and/or Virion?
J. Virol., March 7, 2002; 76(7): 3089 - 3094.
[Full Text] [PDF]


Home page
J. Virol.Home page
A. W. Dangel, S. Hull, T. M. Roberts, and K. Boris-Lawrie
Nuclear Interactions Are Necessary for Translational Enhancement by Spleen Necrosis Virus RU5
J. Virol., March 7, 2002; 76(7): 3292 - 3300.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. B. Buck, X. Shen, M. A. Egan, T. C. Pierson, C. M. Walker, and R. F. Siliciano
The Human Immunodeficiency Virus Type 1 gag Gene Encodes an Internal Ribosome Entry Site
J. Virol., January 1, 2001; 75(1): 181 - 191.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. Butsch and K. Boris-Lawrie
Translation Is Not Required To Generate Virion Precursor RNA in Human Immunodeficiency Virus Type 1-Infected T Cells
J. Virol., December 15, 2000; 74(24): 11531 - 11537.
[Abstract] [Full Text]


Home page
J. Virol.Home page
T. M. Roberts and K. Boris-Lawrie
The 5' RNA Terminus of Spleen Necrosis Virus Stimulates Translation of Nonviral mRNA
J. Virol., September 1, 2000; 74(17): 8111 - 8118.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.